دورية أكاديمية
أعرض في EDS

Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria.

التفاصيل البيبلوغرافية
العنوان: Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria.
المؤلفون: Anejo-Okopi J; Department of Microbiology, University of Jos, Jos, Nigeria.; AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria., Okeke E; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Davwar PM; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Onwuamah C; Center for Human Virology and Genomics Nigeria Institute of Medical Research, Lagos, Nigeria., Onywera H; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.; Research, Innovations, and Academics Unit, Tunacare Services Health Providers Limited, Nairobi, Kenya., Omaiye P; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Duguru M; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Okojokwu OJ; Department of Microbiology, University of Jos, Jos, Nigeria., Ujah OI; Department of Community and Family Health, College of Public Health, University of South Florida, Tampa, Florida, United States., Jonathan B; Department of Family Medicine, Plateau State Specialist Hospital, Jos, Nigeria., George CA; Department of Family Medicine, Bingham University Teaching Hospital, Jos, Nigeria., Crown RS; Department of Medical Microbiology and Parasitology, Bingham University Teaching Hospital, Jos, Nigeria., Yakubu FB; Department of Chemical Pathology, Jos University Teaching Hospital, Jos, Nigeria., Sokei JO; Center for Human Virology and Genomics Nigeria Institute of Medical Research, Lagos, Nigeria., Okoli LC; Center for Human Virology and Genomics Nigeria Institute of Medical Research, Lagos, Nigeria., Audu O; Department of Epidemiology and Community Health, Benue State University, Makurdi, Nigeria., Inzaule SC; Department of HIV and Global Hepatitis Program, World Health Organization, Geneva, Switzerland., Abah IO; Department of Pharmacology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Agaba P; AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria.; Department of Family Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Agbaji OO; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Sagay AS; Department of Obstetrics and Gynaecology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Hawkins C; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
المصدر: African journal of laboratory medicine [Afr J Lab Med] 2022 Oct 18; Vol. 11 (1), pp. 1677. Date of Electronic Publication: 2022 Oct 18 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: AOSIS OpenJournals Country of Publication: South Africa NLM ID: 101603205 Publication Model: eCollection Cited Medium: Print ISSN: 2225-2002 (Print) Linking ISSN: 22252002 NLM ISO Abbreviation: Afr J Lab Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Durbanville, South Africa : AOSIS OpenJournals, [2012]-
مستخلص: Background: Previous studies in Nigeria have reported the presence of hepatitis B virus (HBV) genotype E and the availability of immune escape mutants. There is a paucity of data on chronic patients on long-term antiviral therapy for HBV infection.
Objective: This study assessed HBV genotypes and drug resistance variants among patients with chronic HBV infection receiving tenofovir in Jos, Nigeria.
Methods: This cross-sectional study consecutively enrolled 101 patients (51 with HIV/HBV co-infection and 50 with HBV infection only) on antiviral therapy from February 2018 to May 2019 at four hospitals in Jos, Nigeria. DNA quantification of HBV was performed on all samples; 30 samples with detectable viral load were selected for genotyping using Sanger sequencing by targeting the full-length sequences of reverse transcriptase gene of the HBV genome. Phylogenetic analysis was performed with reference sequences from GenBank. Escape mutant and drug resistance analysis were performed using HBV drug resistance interpretation and Geno2pheno.
Results: Only 30 (29.7%) of the 101 study participants had detectable HBV DNA. Of these, six (20.0%) isolates were successfully amplified and sequenced. The identified genotype was E, including escape mutations L127R (16.7%) and G145A (16.7%).
Conclusion: This study revealed exclusive dominance of genotype E in Nigeria. The S gene mutations G145A and L271R are known to be associated with modified antigenicity and impaired serologic assays, which may cause false negatives in the detection of anti-HBV surface antigen. The presence of mutants that are associated with vaccine immune escape may also have diagnostic and vaccine immune response implications.
Competing Interests: The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
(© 2022. The Authors.)
References: Hepatol Res. 2007 Jul;37(s1):S9-S19. (PMID: 17627641)
J Infect Dis. 2004 Jul 15;190(2):400-8. (PMID: 15216479)
Intervirology. 2014;57(3-4):232-6. (PMID: 25034493)
PLoS One. 2016 Jan 14;11(1):e0143869. (PMID: 26764909)
Chin Med J (Engl). 2009 Jul 5;122(13):1585-6. (PMID: 19719953)
Am J Trop Med Hyg. 2016 Oct 5;95(4):902-907. (PMID: 27527630)
Hepatology. 2009 Apr;49(4):1158-65. (PMID: 19263474)
BMC Infect Dis. 2013 Jul 18;13:328. (PMID: 23865777)
J Viral Hepat. 2010 Jan;17(1):23-7. (PMID: 19566788)
Int J Med Sci. 2005;2(1):50-57. (PMID: 15968340)
J Clin Microbiol. 2015 Jun;53(6):1831-5. (PMID: 25788548)
World J Gastroenterol. 2005 Nov 7;11(41):6410-5. (PMID: 16425408)
Oncology. 2011;81 Suppl 1:41-9. (PMID: 22212935)
World J Gastroenterol. 2014 May 14;20(18):5427-34. (PMID: 24833873)
Viruses. 2010 Jun;2(6):1279-1305. (PMID: 21994680)
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549. (PMID: 29722887)
Lancet. 2015 Oct 17;386(10003):1546-55. (PMID: 26231459)
PLoS Negl Trop Dis. 2018 Aug 6;12(8):e0006629. (PMID: 30080852)
J Hepatol. 2006 Feb;44(2):422-31. (PMID: 16364492)
World J Gastroenterol. 2009 Dec 14;15(46):5761-9. (PMID: 19998495)
PLoS One. 2010 Feb 19;5(2):e9297. (PMID: 20174575)
Niger J Clin Pract. 2015 Mar-Apr;18(2):163-72. (PMID: 25665986)
J Viral Hepat. 2011 Oct;18(10):721-9. (PMID: 21914087)
World J Hepatol. 2015 Mar 27;7(3):289-303. (PMID: 25848459)
Rev Med Virol. 2016 Jul;26(4):285-303. (PMID: 27139263)
PLoS One. 2018 Mar 29;13(3):e0195045. (PMID: 29596494)
J Clin Virol. 2013 Sep;58(1):59-66. (PMID: 23871163)
Niger Postgrad Med J. 2019 Apr-Jun;26(2):80-86. (PMID: 31187746)
World J Gastroenterol. 2016 Jan 7;22(1):145-54. (PMID: 26755866)
BMC Bioinformatics. 2004 Aug 19;5:113. (PMID: 15318951)
Lancet. 2016 Sep 10;388(10049):1081-1088. (PMID: 27394647)
Arab J Gastroenterol. 2016 Mar;17(1):34-40. (PMID: 27055927)
J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):279-82. (PMID: 18167643)
Hepatology. 2015 Mar;61(3):823-33. (PMID: 25418031)
World J Hepatol. 2018 Nov 27;10(11):807-821. (PMID: 30533182)
Afr J Lab Med. 2019 Jun 27;8(1):622. (PMID: 31309044)
Springerplus. 2015 Feb 01;4:43. (PMID: 25674500)
J Virol. 2009 Oct;83(20):10538-47. (PMID: 19640977)
Pan Afr Med J. 2016 Oct 01;25(Suppl 1):5. (PMID: 28210373)
Jpn J Infect Dis. 2012;65(6):476-82. (PMID: 23183198)
Trop Med Int Health. 2017 Jun;22(6):744-754. (PMID: 28376292)
معلومات مُعتمدة: 001 International WHO_ World Health Organization; D43 TW010543 United States TW FIC NIH HHS
فهرسة مساهمة: Keywords: antiviral drug resistance; chronic hepatitis B; genotyping; hepatitis B virus (HBV)
تواريخ الأحداث: Date Created: 20221107 Latest Revision: 20240214
رمز التحديث: 20240214
مُعرف محوري في PubMed: PMC9634812
DOI: 10.4102/ajlm.v11i1.1677
PMID: 36337771
قاعدة البيانات: MEDLINE
الوصف
تدمد:2225-2002
DOI:10.4102/ajlm.v11i1.1677